Cramp Seal Plus Tab
Lycolanz Power Gold
Roseehip-OD Improve Joint Flexibility
See Our Products
have several product candidates in development that we believe have been significantly de-risked.
We offer a refreshing new approach with a dedicated focus on enhancing value for our customers. It’s about treatment versus care by delivering patient focused medicines development.
Our Best Product
Lycolanz Power Gold
Roseehip-OD Improve Joint Flexibility
Development pipeline
Balanced mix of new substance developments and life cycle management opportunities.
We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
01
Research & Preclinical
02
Starting Phase
03
Medium Phase
04
Finishing Phase
05
After Drug Approval
06
Drugs Production
License Certificate
we are dedicated to pioneering innovative healthcare solutions that positively impact lives worldwide. With our unwavering commitment to excellence and cutting-edge research, we have secured government approval and possess a prestigious drug license (License No. 22223074003606), ensuring the highest standards of quality, safety, and efficacy in all our pharmaceutical products.
Driven by a passion for healthcare advancement, we aspire to be at the forefront of pharmaceutical innovation. Our vision is to create a healthier world by providing accessible, high-quality medications that address unmet medical needs and enhance the well-being of individuals globally.